CA2158866A1 - Hepatitis b escape mutant specific binding molecules - Google Patents

Hepatitis b escape mutant specific binding molecules

Info

Publication number
CA2158866A1
CA2158866A1 CA002158866A CA2158866A CA2158866A1 CA 2158866 A1 CA2158866 A1 CA 2158866A1 CA 002158866 A CA002158866 A CA 002158866A CA 2158866 A CA2158866 A CA 2158866A CA 2158866 A1 CA2158866 A1 CA 2158866A1
Authority
CA
Canada
Prior art keywords
smh
hbs
specific binding
ecacc
hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002158866A
Other languages
English (en)
French (fr)
Inventor
Jennifer Anne Waters
William Frederick Carman
Howard Christopher Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial College of Science Technology and Medicine
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939306087A external-priority patent/GB9306087D0/en
Priority claimed from GB939311526A external-priority patent/GB9311526D0/en
Application filed by Individual filed Critical Individual
Publication of CA2158866A1 publication Critical patent/CA2158866A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002158866A 1993-03-24 1994-03-24 Hepatitis b escape mutant specific binding molecules Abandoned CA2158866A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB939306087A GB9306087D0 (en) 1993-03-24 1993-03-24 Specific binding molecules and their uses
GB9306087.9 1993-03-24
GB9311526.9 1993-06-04
GB939311526A GB9311526D0 (en) 1993-06-04 1993-06-04 Specific binding molecules and their uses

Publications (1)

Publication Number Publication Date
CA2158866A1 true CA2158866A1 (en) 1994-09-29

Family

ID=26302640

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002158866A Abandoned CA2158866A1 (en) 1993-03-24 1994-03-24 Hepatitis b escape mutant specific binding molecules

Country Status (9)

Country Link
EP (1) EP0689605A1 (no)
JP (1) JPH08510635A (no)
CN (1) CN1121357A (no)
AU (1) AU681636B2 (no)
CA (1) CA2158866A1 (no)
NO (1) NO953749L (no)
NZ (1) NZ262929A (no)
PL (1) PL310699A1 (no)
WO (1) WO1994021812A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9608626D0 (en) * 1996-04-25 1996-07-03 Univ College Of London Hepatitis b monoclonal antibodies
EP0919568A1 (en) 1997-12-01 1999-06-02 Sorin Diagnostics S.r.l. Escape mutant of the surface antigen of hepatitis B virus
AUPP967999A0 (en) * 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
WO2006085918A2 (en) * 2004-06-07 2006-08-17 Novartis Vaccines And Diagnostics Inc. Rabbit monoclonal antibodies to hepatitis b surface antigens and methods of using the same
ES2428630T3 (es) 2004-09-22 2013-11-08 Advanced Life Science Institute, Inc. Método para detectar el antígeno s del virus de la hepatitis B

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007024D0 (en) * 1990-03-29 1990-05-30 Imperial College Novel vaccine
CA2067003A1 (en) * 1991-04-29 1992-10-30 Peter J. Kniskern Hbsag escape mutant vaccine

Also Published As

Publication number Publication date
AU681636B2 (en) 1997-09-04
JPH08510635A (ja) 1996-11-12
EP0689605A1 (en) 1996-01-03
NO953749L (no) 1995-11-22
NZ262929A (en) 1997-08-22
WO1994021812A2 (en) 1994-09-29
CN1121357A (zh) 1996-04-24
AU6287094A (en) 1994-10-11
NO953749D0 (no) 1995-09-22
PL310699A1 (en) 1995-12-27
WO1994021812A3 (en) 1994-11-10

Similar Documents

Publication Publication Date Title
US6030616A (en) Hepatitis B escape mutant specific binding molecules
JP3574664B2 (ja) 抗ｈｂｖ抗体
US5030565A (en) Polypeptide-induced monoclonal receptors to protein ligands
JP3672933B2 (ja) 抗ｈｂｖ抗体
EP0101506A1 (en) MATERIALS AND METHODS FOR VACCINATION AGAINST THE HERPES SIMPLEX VIRUS.
Pohl et al. A human monoclonal antibody that recognizes viral polypeptides and in vitro translation products of the genome of the hepatitis D virus
EP1724285B1 (en) Anti-HBs monoclonal antibodies
EP0904378B1 (en) Hepatitis b monoclonal antibodies
Oldstone et al. Effect of chronic viral infection on the immune system: I. comparison of the immune responsiveness of mice chronically infected with LCM virus with that of noninfected mice
Shih et al. Production of monoclonal antibodies against hepatitis B surface antigen (HBsAg) by somatic cell hybrids
WO2020186687A1 (zh) 一种特异性结合四种血清型登革病毒的人源抗体
CA2158866A1 (en) Hepatitis b escape mutant specific binding molecules
JP5033298B2 (ja) Ｃ型肝炎ウイルスｅ２糖蛋白質に対するヒトモノクローナル抗体
EP0537856A1 (en) Monoclonal antibodies to hepatitis C virus
Li et al. Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1
Howes et al. Mouse hybrid cell lines produce antibodies to herpes simplex virus type 1
Levy et al. Purification of monoclonal antibodies from mouse ascites eliminates contaminating infectious mouse type C viruses and nucleic acids.
KR100281163B1 (ko) 비형 간염 표면 항원에 대해 활성적인 인체 단일클론 항체의 제조방법
EP0993470B1 (en) Antibodies and other binding molecules specific for hepatitis b viral antigens
CA2254931C (en) Human monoclonal antibodies to the hepatitis b surface antigen
Colucci et al. Interactions between hepatitis B virus and polymeric human serum albumin II. Development of syngeneic monoclonal anti‐anti‐idiotypes which mimic hepatitis B surface antigen in the induction of immune responsiveness
WO2022025129A1 (ja) 新規な抗ＨＢｓ免疫グロブリンの製造方法
Tabll et al. Establishment of hybrid cell lines producing monoclonal antibodies to a synthetic peptide from the E1 region of the hepatitis C virus
CA2162370A1 (en) Composition of antibodies against hepatitis b surface antigen
Ben-Porath et al. Monoclonal antibodies as diagnostic probes in the etiology of hepatitis

Legal Events

Date Code Title Description
FZDE Dead